These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 27576197

  • 1. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.
    Zhang Z, Duan Q, Zhao H, Liu T, Wu H, Shen Q, Wang C, Yin T.
    Cancer Lett; 2016 Nov 01; 382(1):53-63. PubMed ID: 27576197
    [Abstract] [Full Text] [Related]

  • 2. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Yin T, Zhang Z, Cao B, Duan Q, Shi P, Zhao H, Camara SN, Shen Q, Wang C.
    Oncotarget; 2016 Jun 14; 7(24):37192-37204. PubMed ID: 27177084
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.
    Zhang Z, Han H, Rong Y, Zhu K, Zhu Z, Tang Z, Xiong C, Tao J.
    J Exp Clin Cancer Res; 2018 Nov 28; 37(1):291. PubMed ID: 30486896
    [Abstract] [Full Text] [Related]

  • 4. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK, Mondal G, Kumar V, Kattel K, Mahato RI.
    Cancer Lett; 2017 Aug 28; 402():1-8. PubMed ID: 28536008
    [Abstract] [Full Text] [Related]

  • 5. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
    Zhang Z, Wang F, Du C, Guo H, Ma L, Liu X, Kornmann M, Tian X, Yang Y.
    Cancer Lett; 2017 Aug 28; 402():213-224. PubMed ID: 28602977
    [Abstract] [Full Text] [Related]

  • 6. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.
    Arora S, Bhardwaj A, Singh S, Srivastava SK, McClellan S, Nirodi CS, Piazza GA, Grizzle WE, Owen LB, Singh AP.
    J Biol Chem; 2013 Jul 19; 288(29):21197-21207. PubMed ID: 23740244
    [Abstract] [Full Text] [Related]

  • 7. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
    Xu BQ, Fu ZG, Meng Y, Wu XQ, Wu B, Xu L, Jiang JL, Li L, Chen ZN.
    Oncotarget; 2016 Sep 20; 7(38):62177-62193. PubMed ID: 27556697
    [Abstract] [Full Text] [Related]

  • 8. Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion via NF-κB inhibition.
    Li K, Zhang Z, Mei Y, Yang Q, Qiao S, Ni C, Yao Y, Li X, Li M, Wei D, Fu W, Guo X, Huang X, Yang H.
    Theranostics; 2021 Sep 20; 11(7):3196-3212. PubMed ID: 33537082
    [Abstract] [Full Text] [Related]

  • 9. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
    Liu C, Shi J, Li Q, Li Z, Lou C, Zhao Q, Zhu Y, Zhan F, Lian J, Wang B, Guan X, Fang L, Li Z, Wang Y, Zhou B, Yao Y, Zhang Y.
    Clin Sci (Lond); 2019 Mar 15; 133(5):645-663. PubMed ID: 30782607
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells.
    Gong J, Muñoz AR, Pingali S, Payton-Stewart F, Chan DE, Freeman JW, Ghosh R, Kumar AP.
    Mol Carcinog; 2017 Feb 15; 56(2):402-411. PubMed ID: 27208550
    [Abstract] [Full Text] [Related]

  • 11. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
    Liu J, Ma J, Wu Z, Li W, Zhang D, Han L, Wang F, Reindl KM, Wu E, Ma Q.
    BMC Cancer; 2014 Sep 20; 14():686. PubMed ID: 25240403
    [Abstract] [Full Text] [Related]

  • 12. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H, Camaj P, Renner A, Ischenko I, Zhao Y, Krebs S, Mysliwietz J, Jäckel C, Nelson PJ, Blum H, Jauch KW, Ellwart JW, Bruns CJ.
    Target Oncol; 2015 Jun 20; 10(2):215-27. PubMed ID: 24950733
    [Abstract] [Full Text] [Related]

  • 13. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.
    Holcomb BK, Yip-Schneider MT, Waters JA, Beane JD, Crooks PA, Schmidt CM.
    J Gastrointest Surg; 2012 Jul 20; 16(7):1333-40. PubMed ID: 22618517
    [Abstract] [Full Text] [Related]

  • 14. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.
    Zhou C, Qian W, Ma J, Cheng L, Jiang Z, Yan B, Li J, Duan W, Sun L, Cao J, Wang F, Wu E, Wu Z, Ma Q, Li X.
    Cell Prolif; 2019 Jan 20; 52(1):e12514. PubMed ID: 30341797
    [Abstract] [Full Text] [Related]

  • 15. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.
    Melisi D, Xia Q, Paradiso G, Ling J, Moccia T, Carbone C, Budillon A, Abbruzzese JL, Chiao PJ.
    J Natl Cancer Inst; 2011 Aug 03; 103(15):1190-204. PubMed ID: 21743023
    [Abstract] [Full Text] [Related]

  • 16. Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway.
    Yu C, Chen S, Guo Y, Sun C.
    Theranostics; 2018 Aug 03; 8(12):3224-3236. PubMed ID: 29930725
    [Abstract] [Full Text] [Related]

  • 17. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
    Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH.
    Cancer Prev Res (Phila); 2012 Mar 03; 5(3):355-64. PubMed ID: 22086681
    [Abstract] [Full Text] [Related]

  • 18. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
    Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.
    Cancer Res; 2010 Nov 01; 70(21):8695-705. PubMed ID: 20864511
    [Abstract] [Full Text] [Related]

  • 19. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine.
    Yang MC, Wang HC, Hou YC, Tung HL, Chiu TJ, Shan YS.
    Mol Cancer; 2015 Oct 12; 14():179. PubMed ID: 26458814
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells.
    Zhao H, Duan Q, Zhang Z, Li H, Wu H, Shen Q, Wang C, Yin T.
    J Cell Mol Med; 2017 Sep 12; 21(9):2055-2067. PubMed ID: 28244691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.